The EU claims data exclusivity is required under international law. It is not. It also claims that there will be no harm to access to medicines. But other countries have learned the hard way how harmful it can be.
Une simple signature à Bruxelles peut-elle provoquer une catastrophe humanitaire ? Nous pourrions bientôt en avoir la preuve, et le nombre de victimes serait alors très élevé.
Alors que des responsables indiens et européens se rencontrent à Bruxelles pour mettre au point les détails d’un accord de libre-échange, des activistes de la société civile s’inquiètent que l’accord puisse déboucher sur une protection renforcée de la propriété intellectuelle qui pourrait réduire l’accès aux médicaments génériques indiens bon marché.
MSF staff and supporters rally outside the offices of the European Commission to deliver an open letter of protest against ongoing trade talks between the European Union and India that could damage access to affordable medicines.
Canada’s pharmaceutical industry and the European Union have been quietly lobbying for changes that could give brand-name drugs several years more patent protection here — and potentially add hundreds of millions of dollars to Canadian medication costs annually.
Hundreds of public interest groups across the world have jointly urged prime minister Manmohan Singh not to sign the proposed free trade agreement (FTA) with European Union as the Centre’s role in medicines supply is under threat due to the intellectual property provisions included in the pact.
The EC is seeking a trade agreement with India which will restrict its generic companies from making cheap copycat drugs for poor countries, says MSF, which launches a campaign to oppose this and other allegedly restrictive EC practices today
A l’occasion du sommet Asie-Europe qui a lieu à Bruxelles, diverses organisations et syndicats ont symboliquement dénoncé lundi après-midi au rond-point Schuman l’évocation par la Commission européenne des droits de propriété intellectuelle dans un accord de libre-échange avec l’Inde, mettant ainsi en danger sa production de médicaments génériques.
We are calling for an international week of joint action from 4 October 2010 to 9 October 2010 to call upon the Government of India to reject
the EU-India FTA, especially the provisions relating to intellectual
property rights and investment.
El Foro representa a organizaciones de la sociedad civil asiática y europea: recordó hoy a sus líderes políticos, reunidos en la cumbre UE-ASEM en Bruselas, que los TLC son "perjudiciales para la salud".
We request organizations and individuals across the world to join Delhi Network of Positive People in a sign on letter to issue a appeal to the Indian government to ’not sign on’ to any IP provisions in the FTA negotiations.
The Hindu
’FTAs may close tap on affordable drugs’
India’s ability to produce low-cost generics may be impacted, says UN-backed agency’.
By P.T. Jyothi Datta
18 September 2010
Mumbai, Sept. 16/In a rare public endorsement of a concern gaining momentum in various quarters, Unitaid has expressed concerns about the impact Free Trade Agreements would have on India’s capacity to make affordable medicines for domestic and overseas markets.
The United-Nations supported Unitaid is an international (...)
If commerce ministry officials have their way in negotiations, all future free trade agreements (FTA) will include a clause protecting India’s interests against third-party agreements, which include FTA partner nations.
India has said that it will not compromise on issues related to health and people’s right to medicine in the bilateral trade and investment agreement being negotiated with the European Union.
There are already reports that India and the European Union will have a free-trade agreement ready by the end of August, causing more nervous chatter here in India
DNP+ and MSF Access Campaign India have set up a blog about the ongoing negotiations of a number of multi- and bilateral free trade agreements, which harm the access to essential medicines.
HAI (Health Action International) Europe and HAI Latin America have formed an alliance to monitor and lobby negotiations on Association Agreements between the EU and the countries of the Andean region on Intellectual Property Rights demanded by the EU which are likely to have a negative effect on Access to Essential Medicines.
A submission to the Australian Senate Select Committee on the US-Australia Free Trade Agreement by Prof Peter Drahos, Dr Thomas Faunce, Martyn Goddard and
Prof David Henry (May 2004)